-
Most Popular
Search Results
240 results for esys
Lucid Stock Warning: LCID Offers Little Upside Ahead. Steer Clear.
Lucid stock is overly reliant on Saudi PIF funding, while continuous cash burn and frequent recalls pose substantial risks.
Q3’s Rising Stars: 3 Energy Stocks for Your Must-Watch List
Uncover the three energy stocks to watch in Q3. Investing in these now may get you ahead of market trends prior to the upcoming election.
Rivian Stock Analysis: Why Investors Should Hold Off Despite $5B VW Deal
While investors might be excited about RIVN stock and its prospects following Q2 earnings, the long run still seems uncertain.
3 Stocks With the Largest 52-Week Gains
These are some of the stocks with largest 52-week gains in the S&P 500. All are connected to the generative AI rally.
3 Airline Stocks That Were Unscathed by the CrowdStrike Outage
Many airline stocks experienced panic as a result of the CrowdStrike outage but these three seemed almost entirely unaffected.
Q3’s Rising Stars: 3 S&P 500 Stocks for Your Must-Watch List
Looking for stock ideas? These are some of the top S&P 500 stocks to watch that can deliver long-term gains for patient investors.
3 Companies Gearing Up for a Stock Split
These stock split candidates could follow the route of Nvidia, Walmart and Chipotle Mexican Green in the near future.
The Top 3 Biotech Stocks to Buy Now Summer 2024
These biotech stocks are well-positioned to generate high returns for investors due to their significant growth prospects.
Steer Clear of Nio Stock as It Battles EU Tariffs and Stiff Competition
Let’s dive into whether Chinese EV maker Nio is worth buying, as NIO stock sees strong surges higher in recent days.
Tesla Resistance Levels: Bulls Must Clear Post-Earnings Hurdles!
Watch closely for hard-to-break Tesla resistance levels, as an earnings disaster means Tesla stock has a lot of catching up to do.
CrowdStrike Stock Forecast: Temporary Tech Outage Sets Up a Turnaround
You might not expect an optimistic CrowdStrike forecast, but oversold conditions indicate strong recovery prospects for CrowdStrike stock.
3 Stocks That Could See Increased Demand Thanks to the CrowdStrike Outage
The CrowdStrike outage caused IT systems worldwide to go down but opened up opportunities for rivals to take share from the market leader.
Tesla Stock Warning: Musk’s Distractions and Risky Ventures Spark ‘D’ Rating
It might be difficult for Tesla stock owners to relax and stay in the trade if Tesla’s mercurial chief executive keeps getting distracted.
3 Overlooked Stocks Poised for a Breakout Very Soon
Discover three overlooked breakout stocks with solid growth prospects, perfect for enhancing your investment portfolio.
Toxic Influencer Marketing: How Roaring Kitty Brought Social Media to the Stock Market
Roaring Kitty’s return to social media has sparked concern from regulators. Is Keith Gill bringing toxic influencer marketing to finance?
3 Undervalued Tech Stocks That Could 5X Your Money in the Next 5 Years
Shopify, GigaCloud Technology, and Payoneer are the top 3 undervalued tech stocks to buy that could 5X your money in 5 years.
3 Top-Performing Stocks Beating the Big Names in 2024
The following top-performing stocks may continue to gain as the Magnificent Seven runs out of steam in July.
Don’t Delay! 3 Stocks to Buy BEFORE Q2 Earnings.
These stocks to buy before earnings are likely to jump higher after the companies behind them report their Q2 financial results.
3 Hypergrowth Stocks That Speculators Should Keep Tabs On
While a high-risk proposition, these hypergrowth stocks can potentially bring enormous returns in a short period of time.
7 Explosive Growth Stocks Set to Soar in 2024
These seven explosive growth stocks across various sectors have the potential to deliver substantial returns for investors in 2024.
3 Stocks With the Highest Short Interest: July 29, 2024
Sometimes short-sellers are the smartest guys in the room but will these stocks with the highest short interest make them look dumb?
3 Growth Stocks That Are Likely to Join the S&P 500 Soon
These potential S&P 500 additions are shaping up to deliver noteworthy long-term gains for patient investors.
5 – 10 of 240 results
